Gradient Investments’s ResMed RMD Stock Holding History

Gradient Investments’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-10	Closed	-$1.72K	–	1710
2023 Q4	$1.72K	Hold	10	–	–	﹤0.01%	1269
2023 Q3	$1.48K	Buy	10 +5	+100%	+$904	﹤0.01%	1261
2023 Q2	$1.09K	Buy	+5	New	+$1.11K	﹤0.01%	1334
2020 Q2	–	Sell	-5	Closed	-$1K	–	1172
2020 Q1	$1K	Buy	+5	New	+$796	﹤0.01%	1029
2019 Q4	–	Sell	-6	Closed	-$1K	–	1205
2019 Q3	$1K	Buy	+6	New	+$786	﹤0.01%	1038
2018 Q1	–	Sell	-12	Closed	-$1K	–	1136
2017 Q4	$1K	Buy	+12	New	+$991	﹤0.01%	942

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Gradient Investments's RMD Position: Q1 2024 in Review

Gradient Investments sold out of ResMed (RMD) in Q1 2024, closing a stake of 10 shares — an estimated $1.72K sold.

Gradient Investments first reported a position in RMD in Q4 2017 and held it in 6 quarters. The position peaked at $1.72K in Q4 2023. 718 funds tracked by Wall St. Rank hold RMD as of Q1 2024.

Gradient Investments reported no remaining ResMed position as of Q1 2024 after selling out during the quarter.
Gradient Investments sold 10 ResMed shares in Q1 2024, an estimated $1.72K.
Gradient Investments first reported a position in ResMed in Q4 2017 and held it in 6 quarters.
Gradient Investments's ResMed position peaked at $1.72K in Q4 2023.
718 funds tracked by Wall St. Rank held ResMed as of Q1 2024.

Based on Gradient Investments's 13F filing for Q1 2024, filed 23 Apr 2024.